Delivery Order SPE2DB20D1100-SPE2DB25FD2Y3
Award Date
7/8/25
Potential Completion Date
7/9/25
Potential Value
$45K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of LUPRON DEPOT-PED 11.25 MG 3MOS medication to the Defense Logistics Agency (DLA). The $86,491.75 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of September 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the procurement of LUPRON DEPOT-PED 11.25 MG KITS, a pharmaceutical product, by the Defense Logistics Agency (DLA). The $8,504.05 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of July 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award, valued at $8,657.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LUPRON DEPOT-PED 11.25 MG 3MOS, a specialty medication, with a performance period through May 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is for the pharmaceutical product Lupron Depot-Ped 11.25 mg 3-month injection, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $50,605.76 fixed-price delivery order contract has a completion date of January 30, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $97,785.07 Firm Fixed Price Delivery Order is for the supply of LUPRON DEPOT-PED 11.25 MG 3MOS, a specialized pharmaceutical product. The contract has a period of performance through November 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,154.18, is for the delivery of the medication Lupron Depot-Ped 11.25 mg 3 months, a treatment used in pediatric healthcare. The contract is a firm fixed-price delivery order with a completion date of March 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $47,237.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LUPRON DEPOT-PED 11.25 MG 3MOS, a specialty medication, with a completion date of June 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,578.35 firm fixed-price delivery order is for Lupron Depot-Ped 30 mg 3-month kits, a medication used to treat central precocious puberty. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical. This IDC serves as a primary...
This federal contract award to AmerisourceBergen Drug Corp is a Delivery Order valued at $16,858.52 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the pharmaceutical product Lupron Depot-Ped 11.25 mg 3 months. The award has a completion date of October 30, 2024 and a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. As a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $54,256.97 delivery order contract is for the supply of LUPRON DEPOT-PED 11.25 MG 3MOS, a specialty medication, with a completion date of August 12, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...